Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Receivables: 2019-2025

Historic Receivables for IM Cannabis (IMCC) over the last 2 years, with Jun 2025 value amounting to $9.0 million.

  • IM Cannabis' Receivables fell 21.47% to $9.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $36.9 million, marking a year-over-year increase of 8.26%. This contributed to the annual value of $10.3 million for FY2024, which is 61.48% up from last year.
  • IM Cannabis' Receivables amounted to $9.0 million in Q2 2025, which was down 10.36% from $10.1 million recorded in Q4 2024.
  • Over the past 5 years, IM Cannabis' Receivables peaked at $21.1 million during Q3 2021, and registered a low of $1.3 million during Q2 2022.
  • Over the past 3 years, IM Cannabis' median Receivables value was $9.8 million (recorded in 2023), while the average stood at $9.3 million.
  • Per our database at Business Quant, IM Cannabis' Receivables spiked by 1,220.98% in 2021 and then plummeted by 81.18% in 2022.
  • Quarterly analysis of 5 years shows IM Cannabis' Receivables stood at $14.7 million in 2021, then crashed by 55.44% to $6.5 million in 2022, then dropped by 3.52% to $6.3 million in 2023, then skyrocketed by 59.69% to $10.1 million in 2024, then fell by 21.47% to $9.0 million in 2025.
  • Its Receivables stands at $9.0 million for Q2 2025, versus $10.1 million for Q4 2024 and $11.5 million for Q2 2024.